BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 29076027)

  • 21. Exosomal miR-106b serves as a novel marker for lung cancer and promotes cancer metastasis via targeting PTEN.
    Sun S; Chen H; Xu C; Zhang Y; Zhang Q; Chen L; Ding Q; Deng Z
    Life Sci; 2020 Mar; 244():117297. PubMed ID: 31954745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypoxic Glioma Cell-Secreted Exosomal miR-301a Activates Wnt/β-catenin Signaling and Promotes Radiation Resistance by Targeting TCEAL7.
    Yue X; Lan F; Xia T
    Mol Ther; 2019 Nov; 27(11):1939-1949. PubMed ID: 31402274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of exosomal microRNA-224 in development of hepatocellular carcinoma and its diagnostic and prognostic value.
    Cui Y; Xu HF; Liu MY; Xu YJ; He JC; Zhou Y; Cang SD
    World J Gastroenterol; 2019 Apr; 25(15):1890-1898. PubMed ID: 31057302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.
    Yang L; Xu Q; Xie H; Gu G; Jiang J
    Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-Throughput Sequencing-Based Identification of Serum Exosomal Differential miRNAs in High-Grade Glioma and Intracranial Lymphoma.
    Wang S; Xu Z; Zhang C; Yu R; Jiang J; Wang C; Qu C
    Biomed Res Int; 2020; 2020():2102645. PubMed ID: 33083454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential biomarkers in NASH-induced liver cirrhosis with hepatocellular carcinoma: A preliminary work on roles of exosomal miR-182, miR-301a, and miR-373.
    Muhammad Yusuf AN; Raja Ali RA; Muhammad Nawawi KN; Mokhtar NM
    Malays J Pathol; 2020 Dec; 42(3):377-384. PubMed ID: 33361718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma miR-454-3p as a potential prognostic indicator in human glioma.
    Shao N; Wang L; Xue L; Wang R; Lan Q
    Neurol Sci; 2015 Feb; 36(2):309-13. PubMed ID: 25190548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma miR-221/222 Family as Novel Descriptive and Prognostic Biomarkers for Glioma.
    Zhang R; Pang B; Xin T; Guo H; Xing Y; Xu S; Feng B; Liu B; Pang Q
    Mol Neurobiol; 2016 Apr; 53(3):1452-1460. PubMed ID: 25636684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma.
    Pang C; Guan Y; Zhao K; Chen L; Bao Y; Cui R; Li G; Wang Y
    Int J Clin Exp Pathol; 2015; 8(5):4943-52. PubMed ID: 26191187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exosomal miR-6803-5p as potential diagnostic and prognostic marker in colorectal cancer.
    Yan S; Jiang Y; Liang C; Cheng M; Jin C; Duan Q; Xu D; Yang L; Zhang X; Ren B; Jin P
    J Cell Biochem; 2018 May; 119(5):4113-4119. PubMed ID: 29240249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer.
    Xu S; Yi XM; Zhou WQ; Cheng W; Ge JP; Zhang ZY
    Int J Clin Exp Pathol; 2015; 8(11):14335-44. PubMed ID: 26823749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Downregulation of serum exosomal miR-216b predicts unfavorable prognosis in patients with non-small cell lung cancer.
    Liu W; Liu J; Zhang Q; Wei L
    Cancer Biomark; 2020; 27(1):113-120. PubMed ID: 31771047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Downregulation of serum exosomal miR-150-5p is associated with poor prognosis in patients with colorectal cancer.
    Zou SL; Chen YL; Ge ZZ; Qu YY; Cao Y; Kang ZX
    Cancer Biomark; 2019; 26(1):69-77. PubMed ID: 31306108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glioma stem cells-derived exosomal miR-26a promotes angiogenesis of microvessel endothelial cells in glioma.
    Wang ZF; Liao F; Wu H; Dai J
    J Exp Clin Cancer Res; 2019 May; 38(1):201. PubMed ID: 31101062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-301a is activated by the Wnt/β-catenin pathway and promotes glioma cell invasion by suppressing SEPT7.
    Yue X; Cao D; Lan F; Pan Q; Xia T; Yu H
    Neuro Oncol; 2016 Sep; 18(9):1288-96. PubMed ID: 27006177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum microRNA-210 as a potential noninvasive biomarker for the diagnosis and prognosis of glioma.
    Lai NS; Wu DG; Fang XG; Lin YC; Chen SS; Li ZB; Xu SS
    Br J Cancer; 2015 Mar; 112(7):1241-6. PubMed ID: 25756397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Profiling of novel circulating microRNAs as a non-invasive biomarker in diagnosis and follow-up of high and low-grade gliomas.
    Tabibkhooei A; Izadpanahi M; Arab A; Zare-Mirzaei A; Minaeian S; Rostami A; Mohsenian A
    Clin Neurol Neurosurg; 2020 Mar; 190():105652. PubMed ID: 31896490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of exosome-encapsulated microRNA-451a as a minimally invasive biomarker for prediction of recurrence and prognosis in pancreatic ductal adenocarcinoma.
    Takahasi K; Iinuma H; Wada K; Minezaki S; Kawamura S; Kainuma M; Ikeda Y; Shibuya M; Miura F; Sano K
    J Hepatobiliary Pancreat Sci; 2018 Feb; 25(2):155-161. PubMed ID: 29130611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-15a down-regulation is associated with adverse prognosis in human glioma.
    Xie T; Liu P; Chen L; Chen Z; Luo Y; Chen X; Feng Y; Luo X
    Clin Transl Oncol; 2015 Jul; 17(7):504-10. PubMed ID: 25575767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells.
    Yoshimura A; Sawada K; Nakamura K; Kinose Y; Nakatsuka E; Kobayashi M; Miyamoto M; Ishida K; Matsumoto Y; Kodama M; Hashimoto K; Mabuchi S; Kimura T
    BMC Cancer; 2018 Nov; 18(1):1065. PubMed ID: 30396333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.